Tag Archives: Alzheimer’s disease

A boomerang drug

Posted on August 18, 2021 by Eugene Ivanov

On June 7, the U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s Disease (AD), its first in nearly two decades. Manufactured by Biogen (a biotech company based in Cambridge, MA) and called Aduhelm, the drug was … Continue reading →

Posted in Global Innovation, Health Care | Tagged , , , , , , | Leave a comment

A silver bullet that was not

Posted on July 11, 2014 by Eugene Ivanov

There are lies, damned lies and statistics Alzheimer’s disease (AD) is a horrible illness. A progressive neurodegenerative disorder that destroys memory, abstract thinking and cognitive function, it’s the most common cause of dementia in humans, affecting as many as five … Continue reading →

Posted in Health Care | Tagged , , , , , | Leave a comment